AdProTech plc

AdProTech is a new biotechnology company dedicated to turning proteins into better drugs and better drug discovery tools. AdProTech recently opened its new laboratories in Royston near Cambridge, UK and is currently in a rapid growth phase. The company’s focus is on innovative protein engineering and its current research programme is targeted towards the identification and development of novel protein therapeutics for the treatment of cardiovascular, inflammatory and autoimmune disorders.AdProTech has adopted a radical strategy which differentiates it significantly from other protein engineering based companies, in that post translational modification (PTM) of proteins is taken to be vital in the development of a working protein therapeutic agent. By attempting to mimic nature where PTM often dictates protein activity, AdProTech has successfully developed several proprietary technologies, which produce highly effective protein therapeutic agents. The most advanced of these is PRODAPTIN™ M which permits the engineering of a membrane "address" into a protein therapeutic agent to target it to the site where it is most effective.

Contact Details: Chesterford Research Park, Little Chesterford Safron Waldon Essex CB10 1XL United Kingdom Tel: 0870 444 6144 Fax: 0870 444 7244 Email: info@adpro.co.uk WWW: www.adprotech.co.uk/

Loading...

BioNews Results for AdProTech plc:
Elan Corporation plc : Total Voting Rights	Investegate:  Oct 30 2009 1:54PM Matching: plc
REG-Elan Corporation PLC Elan Corporation Plc Announces Expiration of Tender Offer for 7% Senior Fixed Rate	Reuters:  Oct 30 2009 8:09AM Matching: plc
Comment: Shire shares shine	ShareCast:  Oct 30 2009 8:51PM Matching: plc
Elan Corporation PLC UK Regulatory Announcement: Elan Corporation Plc Announces Expiration of Tender Offer for	Business Wire UK:  Oct 30 2009 7:04AM Matching: plc
Saturday, October 31	Plymouth Evening Herald:  Oct 30 2009 4:59AM Matching: plc
Promote your company here: BioNewsCast - Press Release Distribution	→View more AdProTech plc news.

AdProTech plc Patents:
US Patent No.	Title
5859223	Soluble CR1 derivatives
5833989	Soluble CR1 derivatives

AdProTech plc (PRW) Financial information Links from Barchart
PRW Quote from from Barchart.com
PRW Chart from from Barchart.com
PRW Profile from from Barchart.com
PRW Opinion from from Barchart.com
→View more AdProTech plc finance information.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 1302 times since April 2007, the link to the organisation's website has been followed 328 times

Recent Search Terms used to find this page: adprotech plc | adprotech plc | Adprotech plc | Adprotech plc | Adprotech | Adprotech Plc | AdProTech | Adprotech PLC | AdProTech Plc | AdProTech | .

Search for more companies in Safron Waldon

Search for more companies in Essex

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for AdProTech plc